Lipsky, P. E., Calabrese, L. H., Kavanaugh, A., Sundy, J. S., Wright, D., Wolfson, M., & Becker, M. A. (2014). Pegloticase immunogenicity: The relationship between efficacy and antibody development in patients treated for refractory chronic gout. BioMed Central.
Citação norma ChicagoLipsky, Peter E., Leonard H. Calabrese, Arthur Kavanaugh, John S. Sundy, David Wright, Marsha Wolfson, and Michael A. Becker. Pegloticase Immunogenicity: The Relationship between Efficacy and Antibody Development in Patients Treated for Refractory Chronic Gout. BioMed Central, 2014.
MLA引文Lipsky, Peter E., et al. Pegloticase Immunogenicity: The Relationship between Efficacy and Antibody Development in Patients Treated for Refractory Chronic Gout. BioMed Central, 2014.